Literature DB >> 24486950

Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Wonseok Kang1, Pil Soo Sung2, Su-Hyung Park3, Sarah Yoon4, Dong-Yeop Chang2, Seungtaek Kim5, Kwang Hyub Han5, Ja Kyung Kim5, Barbara Rehermann3, Yong-Joon Chwae4, Eui-Cheol Shin6.   

Abstract

BACKGROUND & AIMS: Major histocompatibility complex (MHC) class I-restricted CD8(+) T cells are required for clearance of hepatitis C virus (HCV) infection. MHC class I expression is up-regulated by type I and II interferons (IFNs). However, little is known about the effects of HCV infection on IFN-induced expression of MHC class I.
METHODS: We used the HCV cell culture system (HCVcc) with the genotype 2a Japanese fulminant hepatitis-1 strain to investigate IFN-induced expression of MHC class I and its regulatory mechanisms. HCVcc-infected Huh-7.5 cells were analyzed by flow cytometry, metabolic labeling, immunoprecipitation, and immunoblotting analyses. Protein kinase R (PKR) was knocked down with lentiviruses that express small hairpin RNAs. The functional effects of MHC class I regulation by HCV were demonstrated in co-culture studies, using HCV-specific CD8(+) T cells.
RESULTS: Although the baseline level of MHC class I was not affected by HCV infection, IFN-induced expression of MHC class I was notably attenuated in HCV-infected cells. This was associated with replicating HCV RNA, not with viral protein. HCV infection reduced IFN-induced synthesis of MHC class I protein and induced phosphorylation of PKR and eIF2α. IFN-induced MHC class I expression was restored by small hairpin RNA-mediated knockdown of PKR in HCV-infected cells. Co-culture of HCV-specific CD8(+) T cells and HCV-infected cells that expressed HLA-A2 demonstrated that HCV infection reduced the effector functions of HCV-specific CD8(+) T cells; these functions were restored by small hairpin RNA-mediated knockdown of PKR.
CONCLUSIONS: IFN-induced expression of MHC class I is attenuated in HCV-infected cells by activation of PKR, which reduces the effector functions of HCV-specific CD8(+) T cells. This appears to be an important mechanism by which HCV circumvents antiviral adaptive immune responses.
Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive Immune Response; Antigen Presentation; Immune Evasion; JFH-1

Mesh:

Substances:

Year:  2014        PMID: 24486950      PMCID: PMC4478444          DOI: 10.1053/j.gastro.2014.01.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.

Authors:  D R Taylor; S T Shi; P R Romano; G N Barber; M M Lai
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

2.  Analysis of a successful immune response against hepatitis C virus.

Authors:  S Cooper; A L Erickson; E J Adams; J Kansopon; A J Weiner; D Y Chien; M Houghton; P Parham; C M Walker
Journal:  Immunity       Date:  1999-04       Impact factor: 31.745

Review 3.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

5.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

6.  Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.

Authors:  D Moradpour; B Grabscheid; A R Kammer; G Schmidtke; M Groettrup; H E Blum; A Cerny
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

7.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

8.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

10.  Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.

Authors:  Chien-Te K Tseng; Gary R Klimpel
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  14 in total

1.  Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Authors:  Xuancheng Guo; Taixiang Liu; Hengfei Shi; Jingjing Wang; Ping Ji; Hongwei Wang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

2.  Hepatitis C Virus. Strategies to Evade Antiviral Responses.

Authors:  Nandan S Gokhale; Christine Vazquez; Stacy M Horner
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

Review 3.  Hepatitis C virus and intracellular antiviral response.

Authors:  Jiyoung Lee; Jing-Hsiung J Ou
Journal:  Curr Opin Virol       Date:  2021-12-29       Impact factor: 7.090

4.  Immunoproteasome induction is suppressed in hepatitis C virus-infected cells in a protein kinase R-dependent manner.

Authors:  In Soo Oh; Kathrin Textoris-Taube; Pil Soo Sung; Wonseok Kang; Xenia Gorny; Thilo Kähne; Seon-Hui Hong; Young Joon Choi; Clemens Cammann; Michael Naumann; Jong Hoon Kim; Su-Hyung Park; Ook Joon Yoo; Peter M Kloetzel; Ulrike Seifert; Eui-Cheol Shin
Journal:  Exp Mol Med       Date:  2016-11-11       Impact factor: 8.718

5.  Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression.

Authors:  Megumi Tasaka-Fujita; Nao Sugiyama; Wonseok Kang; Takahiro Masaki; Takahiro Masaski; Asako Murayama; Norie Yamada; Ryuichi Sugiyama; Senko Tsukuda; Koichi Watashi; Yasuhiro Asahina; Naoya Sakamoto; Takaji Wakita; Eui-Cheol Shin; Takanobu Kato
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

Review 6.  CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.

Authors:  Pil Soo Sung; Vito Racanelli; Eui-Cheol Shin
Journal:  Front Immunol       Date:  2014-06-06       Impact factor: 7.561

Review 7.  Contradictory immune response in post liver transplantation hepatitis B and C.

Authors:  Akinobu Takaki; Takahito Yagi; Kazuhide Yamamoto
Journal:  Int J Inflam       Date:  2014-08-24

Review 8.  Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Authors:  Young-Chan Kwon; Ratna B Ray; Ranjit Ray
Journal:  EXCLI J       Date:  2014-08-27       Impact factor: 4.068

Review 9.  Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection.

Authors:  Pil Soo Sung; Eui-Cheol Shin; Seung Kew Yoon
Journal:  Int J Mol Sci       Date:  2015-10-07       Impact factor: 5.923

10.  Hospital-visiting pregnant women signal an increased spread of hepatitis C infection in Khyber Pakhtunkhwa region of Pakistan.

Authors:  Zobia Afsheen; Bashir Ahmad; Shumaila Bashir
Journal:  Virol J       Date:  2017-10-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.